patterns in blood vessels with the directional ultrasonic Doppler technique through a transcutaneous approach. Jap Circ J 37: 735, 1973 37. Kalmanson This study examined a larger series of patients undergoing cardiac catheterization to determine the sensitivity of each right ventricular systolic time interval (RVSTI) in the prediction of PA pressure and PVR. Since the RPEP is prolonged in patients with CRBBB or congestive cardiomyopathy, the evaluation of the pulmonary vascular bed in patients with these conditions has been a problem. A small number of children with CRBBB or cardiomyopathy were included in the study to determine whether RVSTIs could be used in the evaluation of their PA pressure and PVR. 
THE ASSOCIATION BETWEEN ELEVATED PUL-MONARY ARTERY (PA) PRESSURE and characteristic alterations in the pulmonic valve echocardiogram has been established.1'3 Qualitative assessment of the pulmonic valve echogram in patients with pulmonary hypertension has included loss of the atrial systolic "a" dip and increased rate of cusp opening. Nanda et al. described lengthening of the right ventricular pre-ejection period (RPEP), indexed for heart rate (HR), in adult patients with elevated PA pressure.2 Hirschfeld et al. measured the RPEP and the right ventricular ejection time (RVET) in 64 pediatric patients undergoing cardiac catheterization and demonstrated a strong correlation between PA diastolic pressure and the ratio, degree polynomial of the RPEP/RVET and PA diastolic pressure. The RPEP/RVET allowed prediction of PA diastolic pressure within 10 mm Hg in 85% of the patients. The utility of RPEP/RVET was confirmed in sequential data of 22 patients, in whom alteration in RPEP/RVET accurately reflected the changing PA diastolic pressure. The RPEP/RVET could not be used to assess PA pressure in six patients with congestive cardiomyopathy nor in 18 patients with complete right bundle branch block (CRBBB).
RPEP/RVET (r = 0.72). 3 Silverman et al. analyzed the same data and suggested that RPEP, corrected for HR, provided better correlation with pulmonary vascular resistance than did the RPEP/RVET. 4 Recently, Johnson et al. measured both the RPEP and the interval from the Q wave of the electrocardiogram (ECG) to tricuspid valve closure (QTc) in patients undergoing cardiac catheterization. The derived ratio, (RPEP -QTC)/RVET, showed excellent correlation (r = 0.80) with PA diastolic pressure and could be applied in patients with complete right bundle branch block (CRBBB).5
This study examined a larger series of patients undergoing cardiac catheterization to determine the sensitivity of each right ventricular systolic time interval (RVSTI) in the prediction of PA pressure and PVR. Since the RPEP is prolonged in patients with CRBBB or congestive cardiomyopathy, the evaluation of the pulmonary vascular bed in patients with these conditions has been a problem. A small number of children with CRBBB or cardiomyopathy were included in the study to determine whether RVSTIs could be used in the evaluation of their PA pressure and PVR. Premedication for the catheterization was either droperidol 0.1 mg/kg (maximum 5 mg) or meperidine hydrochloride and hydroxyzine hydrochloride (1.0 to 1.5 mg/kg of each) for all children older than 2 months. Younger children were not premedicated. Light anesthesia, when necessary, was maintained with intravenous ketamine hydrochloride, 1 mg/kg, in patients premedicated with droperidol and with intravenous diazepam, 0.1 mg/kg, in the other patients. Patients with congestive heart failure were treated with digoxin and diuretics, as necessary, before cardiac catheterization.
The PA pressures, PVR, RVSTIs, HR and ages were recorded on computer punch cards and the data were analyzed using a PDP-11 computer (Digital Equipment Corporation). The statistical analyses included simple and multiple linear regression and polynomial regression, using BMD programs 02R and 05R." Subjects Two groups, totaling 314 patients, were evaluated.
Group I Eighty-five normal patients, age 2 months to 21 years, were studied echocardiographically to measure RPEP, RVET and QT,. Each patient was determined to be normal by a pediatric cardiologist on the basis of physical examination, chest X-ray, and ECG or was a volunteer whose physical examination was considered normal; consent was obtained in all cases.
Group II Two-hundred and twenty-nine patients with a variety of congenital and acquired cardiac diseases underwent cardiac catheterization and echocardiographic studies. Since interest centered on RVSTIs as they relate to the pulmonary vascular bed, excluded from this study were patients with transposition of the great arteries. Subgroup Ila (205 patients) had neither CRBBB nor clinically evident myocardial disease. Among Ila were 19 patients who had simultaneous echographic and catheterization studies to determine the potential effects of premedication and anesthesia on RVSTI and 22 patients who were examined sequentially. Eighteen patients were a subgroup (Ilb) with CRBBB, diagnosed by Frank vectorcardiogram (VCG). Six patients in another subgroup (IIc) had congestive cardiomyopathy. All six patients had clinical congestive heart failure, angiographic and echocardiographic evidence of dilated and poorly contractile ventricles, and at catheterization, each had elevated ventricular end-diastolic pressures.
Results

Group I
In normal patients, RPEP and RVET were influenced by HR (table 1, fig. 3 ). RPEP varied inversely with HR (r = -0.71). An insignificant increase in the correlation occurred when the age of the patient was considered. The normal RPEP, corrected for HR, RPEPC, was 109 ± 11 msec (mean ± 1 SD). The RVET also varied inversely with HR and this relationship appeared linear over a range of HR of 50-150 (r = -0.87). A small but significant (P < 0.05) increase in the multiple correlation occurred (0.90) when the age of the patient was also considered. Therefore, RVET was corrected for both HR and age, equation (4) . Normal RVETC was 373 + 21 msec (mean + 1 SD).
RPEP/RVET had little correlation with either HR or age (table 1) . The mean + 2 SD for this ratio extended from 0.17 to 0.33. The (RPEP -QTC)/RVET ratio was determined retrospectively, since no special effort had originally been made to carefully record tricuspid valve closure. This ratio was determined in 20 of 85 normal patients. The mean value was 0.0336 (SD = 0.015) with a range of 0.013 to 0.056. This small sample was insufficient to analyze the potential effects of HR and age on this ratio. There was an inverse association between RVETC and PADP (r = -0.537) (table 2). The relationship appeared nonlinear, but significant residual variability remained when quadratic functions of RVET0 were employed. The correla-HR FIGURE 3. The relationship is shown between heart rate (HR) and both RPEP and RVET in 85 normal patients. The RPEP and R VET decrease with increasing HR, although the RPEP/R VET ratio is independent of HR (see table 1 ; equations I and 3). HR = heart rate; RPEP= right ventricular pre-ejection period; R VET = right ventricular ejection time.
tion increased to 0.586. Patients often had RVETC within one SD of the normal mean (373 ± 21 msec) despite having elevated PADP and PVR. There was poor correlation between RVETC and PVR (r =-0.320, table 2).
RPEP/R VET
The ratio RPEP/RVET allowed the best prediction of PADP. Since the relationship between RPEP/RVET was nonlinear, PADP was studied as a polynomial function of the ratio (table 2) . The correlation between PADP and quadratic function -of the ratio (0.828) was significantly better than the simple correlation (0.781). A statistically significant but numerically unimportant improvement occurred after a third order term was introduced (0.837). A quadratic function of the ratio was adopted for predicting PADP. The predicted PADP at ratios of 0.20, 0.30 and 0.40 was 10, 18 and 39 mm Hg, respectively. The predicted PADP with 95% prediction limits is illustrated in figure 4 . The predicted and actual PA diastolic pressures differed by 10 mm Hg or less in 85% (170/200) patients.
Patients with ratios less than 0.25 would be expected to have a PADP equal to or less than 25 mm Hg 97.5% of the time. In our patients, 62 had ratios less than 0.25, and within this group the maximum PADP encountered was 20 mm Hg. Similarly, patients having a ratio less than 0.30 would be expected to have a PADP equal to or less than 30 mm Hg, 97.5% of the time. In our experience, PADP has almost always (122/125 patients) been less than 20 mm Hg in patients having ratios equal to or less than 0.30. Patients with ratios from 0.30 to 0.35 had PADP that varied from 6 to 50 mm Hg, although most had mild to moderate elevation of their PADP. In this range, there was overlap between patients with normal PADP and those having significant elevation of their PADP. Values of the ratio greater than 0.35 would be expected to correspond with PADP less than 15 mm Hg very infrequently (less than 2.5% of the time). In fact, among 38 patients with ratios equal to or greater than 0.35, only one had PADP less than 20 mm Hg. Most of the patients in this category had PADP in the 30 to 50 mm Hg range. In this series, the patients with severely elevated PADP rarely had ratios exceeding 0.45.
The RPEP/RVET ratio correlated with mean PA pressure and was associated with PVR (table 2) . In each case, however, the residual standard deviation about the regression line was much greater than that for estimated PADP. Resultant prediction bands were broad.
(RPEP -QTC)/RVET
The ratio (RPEP -QTC)/RVET was analyzed as a function of PADP in all group Ila patients in whom this ratio could be calculated (85 of 200 patients). The resultant correlation was good (r = 0.69) and appears linear ( fig. 5 ).
However, the prediction bands are wide and the ratio must be elevated 3 to 4 SD above the normal mean before one can be certain of elevated PADP. Furthermore, false negatives occur, since a few patients had ratios in the normal range despite having elevated PADP. 
Sequential Studies
Sequential echocardiographic studies were available in 22 patients (table 3) . In each patient, the change in RPEP/RVET ratio paralleled the rise or fall in PADP. Six of these patients underwent surgical interventions that lowered their PADP and the remaining 16 had repeat cardiac catheterizations.
Surgical patients had decreasing ratios after a good clinical result from pulmonary artery banding (PAB) (4), patent ductus arteriosus (PDA) ligation (1), and mitral valvuloplasty for rheumatic mitral insufficiency (1) (fig. 6 ). Seven patients had little or no change in ratios and slight or no change in PADP at repeat cardiac catheterization. Six patients had increasing ratios and each had a rise in PADP between examinations. The remaining three patients had decreasing ratios and decreasing PADP. One of these patients progressed from trivial to moderate pulmonic stenosis with ventricular septal defect (VSD). Two had spontaneous decreases in VSD size. The actual and predicted PADP of all sequentially examined patients is shown in fig. 2) .
Group lIb
In patients with CRBBB, the RPEP lengthened secondary to conduction delay in the onset of ventricular systole (table  5) . Therefore, RPEPC and RPEP/RVET falsely imply elevated PADP. On the other hand, RVETC was normal in 16 patients with CRBBB and normal PADP, while the RVETC was more than 2 SD below the normal mean in two patients with elevated PADP.
The ratio (RPEP -QTC)/RVET was analyzed as a function of PADP in 17 of 18 Ilb patients. The resultant linear relationship had an excellent correlation (r = 0.85). However, most of the data were collected on patients with normal PADP and the correlation might be poorer if more patients with elevated PADP had been included. When the data from hIa and Ilb are analyzed together ( fig. 5 ), the correlation was 0.69. 
Group Ilc
In the small group of patients with congestive cardiomyopathy most had normal or near normal PADP ( fig. 7) . However, the RVSTIs were profoundly abnormal. The RPEPC was lengthened, the RVETC shortened and the RPEP/RVET and (RPEP -QTC)/RVET ratios were elevated in all cases. The RPEP/RVET ratio was often more elevated in cardiomyopathy (mean = 0.51) than in Abbreviations: PAP = pulmonary artery pressure; QTc = interval from the Q-wave of the electrocardiogram to trcuspid valve closure; RPEP = right ventricular pre-ejection period; RPEPo = RPEP, corrected for heart rate; RVET = right ventricular ejection time; RVETo = right ventricular ejection time, corrected for both heart rate and age. patients in Ila with pulmonary vascular disease. In two of the patients in this group, incomplete left bundle branch block was present, but none had CRBBB.
Discussion
The RPEP was shown to vary inversely with HR in our normal patients. The increase in RPEP seen with increasing age could be explained entirely on the basis of the coincident decrease in HR. Therefore, age had no significant effect on RPEP. Right ventricular ejection time was most strongly influenced by HR, although a small residual increase in RVET with increasing age after correcting for HR was observed. Values of RPEPC and RVETC derived from our normal population are almost identical to the data reported by Although the youngest normal infant in this study was two months of age, our study of normal newborns indicated that the RPEP/RVET of the neonate approached values found in later infancy by the third day of life.'3 In the present study, normal RPEP/RVET was not significantly influenced by age or HR, and therefore could be used as an index of right ventricular performance throughout a wide range of pediatric age groups. The mean normal RPEP/RVET and its distribution are similar to the previous report. 3 The ratio, (RPEP -QTC)/RVET, described by Johnson et al.,5 was determined in 20 of 85 normal patients, too small a series to comment on the potential influence of HR or age.
This portion of our analysis was retrospective; the QTc interval can usually be recorded. The technique requires the nonsimultaneous recording of RPEP and QT, during identical cycle lengths and phases of respiration. The resultant difference between RPEP and QT, is often less than 10 msec. The wide variability seen in individual ratios may be a result, therefore, of technical problems.
Correlation of RPEPC and RVETC with PADP was poor. RPEPC lengthened and RVETC shortened with increasing PADP. However, the range of normal values often included the corrected intervals of patients having moderate elevation of their PADP. Neither RPEPC nor RVETC was reliable in an individual case for predicting PADP. Implicit in the calculation of RPEPC and RVETC for group lIa was that the influence of HR and age is similar to normal children, despite altered PADP. This may not be valid. The changes in RVSTIs occurring with elevated PADP have been reported previously, but the biologic variability of RPEPC and RVETC limits their usefulness in estimating PADP.
In infants and children in whom it is usually possible to record both anterior and posterior pulmonary valve leaflets, the accurate measurement of RPEP and RVET is uncomplicated. When the anterior leaflet cannot be recorded, the termination of RVET can be difficult to record and might lead to an erroneous RPEP/RVET. One might then confirm the end of RVET with a simultaneously recorded echocardiogram and phonocardiogram.
The RPEP/RVET ratio accentuated reciprocal changes in RPEP and RVET since their sum tends to remain constant as afterload is increased at a constant HR.'4 In addition, patients having dissimilar HR and age may be compared and individual patients may be sequentially examined. Patients with ratios less than or equal to the normal mean (i.e., 0.25) have a greater than 97.5% chance of having PADP less than 25 mm Hg, while the comparable predicted upper limit was 30 mm Hg at a ratio of 0.30. Although our mathematical model allows these upper limits, the vast majority of our patients with ratios less than or equal to 0.30 had a PADP that approximated 10 to 15 mm Hg. Therefore, a ratio less than 0.30 virtually assures a normal PADP.
Patients with ratios greater than 0.35 clearly had elevated PADP. The proposed model contains a lower 2.5% limit of 15 mm Hg with a ratio of 0.35. We suggest from our experience that PADP in patients with ratios greater than 0.35 is almost always greater than 20 mm Hg, and usually exceeds 30 mm Hg. Ratios from 0.30 to 0.35 constituted an area of overlap between normal patients and those with elevated PADP. Biologic variability and the wide range of normal ratios limit the exact estimation of PADP, but an approximation of a particular patient's PADP is feasible.
Sequential examination was very valuable in our patients. In all cases, the RPEP/RVET accurately predicted changes in the pulmonary vascular bed, either after surgical therapy or during the natural history of the disease. It was important to consider both the absolute value of the new ratio and its proportional change from the patient's previous ratio. For example, patient 6 (table 3) had a rise in the ratio from 0.33 to 0.45 between cardiac catheterizations, while patient 4 changed from 0.22 to 0.29. In each case, the changes in PADP were very similar.
The patients who underwent simultaneous echocardiographic and invasive studies demonstrated the sensitivity and reproducibility of this technique in assessing PADP. When the PADP was constant during catheterization, RPEP/RVET ratios computed during and around the time of cardiac catheterization differed only by the error of the technique. On the other hand, when the RPEP/RVET was variable or when it was influenced by administration of oxygen, the altered PADP was correctly predicted. Furthermore, the regression analysis of this group of patients was remarkably similar to the nonsimultaneous group. The potential effects of premedication, anesthesia, and nonsimultaneity therefore appear small and probably would not significantly alter the equations of table 2.
All noninvasive parameters were not reliable in assessing the PVR. In part, this may be a result of the assumptions for several parameters that have to be made in calculating pulmonary blood flow.9 1' Pulmonary artery diastolic pressure, on the other hand, is a single measurement and subject to less error.
In the presence of CRBBB, the onset of right ventricular systole was delayed and neither RPEPC nor RPEP/RVET could be used to in RVSTIs that accompany either CRBBB or poor myocardial contractility, patients not having either of these abnormalities have changes in the RPEP/RVET ratio that appear largely to be the result of changing PADP.
In normal pediatric patients, the RPEP/RVET ratio provides a noninvasive index of right ventricular performance through a wide range of HR and ages. In patients with congenital heart disease, this ratio is superior to either RPEPC or RVETC in estimating the PADP. Although the wide range of normal values limits the sensitivity of the RPEP/RVET ratio in detecting mild increases in PADP, a ratio less than 0.30 clearly implies normal PADP. In patients without CRBBB or cardiomyopathy, the ratio provides a good estimate of PADP. Its greatest strength lies in the sequential evaluation of patients who may at some time need cardiac catheterization or corrective surgery.
number of noninvasive and catheterization characteristics were significant predictors of survival for patients with 70% or greater left main stenosis. Noninvasive descriptors defined a low risk subgroup (one and three-year survivals of 97% and 74%) and a high risk subgroup (one-and three-year survivals of 59%o and 25%). These observations have important implications both in assessing therapeutic interventions and in managing individual patients. most prognostically important single lesion involving the coronary arteries. Long-term mortality for medically treated patients with left main stenosis has been reported by different investigators as 29% at 18 months,2 39%o at two years,3 48% at two years,4 35% at 30 months,5 and 51% at five years.6
Although the prognosis for the overall group of patients with left main stenosis is undoubtedly grave, the prognosis for individual patients must vary. The purposes of this report are: 1) to review the natural history of patients with left main stenosis; 2) to determine the prognostic significance of different degrees of left main stenosis; and 3) to determine if prognostically important descriptors can be identified and used to characterize high and low risk patients with significant left main stenosis.
Methods
During the period from November 1969 to June 1977, 3,498 consecutive patients underwent cardiac catheteriza-
